Jan 7 (Reuters) - The United Arab Emirates' drug regulator has recalled certain Nestle infant formula products after the company recalled specific batches over a potential toxin risk, the state news agency (WAM) reported on Wednesday.
The Emirates Drug Establishment said no illness or adverse events linked to the affected batches have been reported or confirmed, WAM added.
The Qatari ministry of public health has also warned consumers against using specific batches of Nestle infant formula products over suspected contamination with cereulide toxin, the Qatari state news agency reported.
Nestle said late on Monday it was recalling specific batches of its SMA infant formula and follow-on formula due to the potential presence of a toxin that could lead to nausea, vomiting and abdominal cramps.
(Reporting by Ahmed Tolba and Yomna Ehab in Cairo; Editing by Chris Reese and David Gregorio)
LATEST POSTS
- 1
The 15 Best Business visionaries Under 4006.07.2023 - 26 Solid Vehicle Fix Administrations to Keep Your Vehicle in Prime Condition06.06.2024
- 3Lego's $650 Pokémon set is already sold out as demand, preorders surge13.01.2026
- 4Toilet rats? Washington health officials warn of possible rodents in sewer systems after floods20.12.2025
- 5NASA chief Jared Isaacman says Texas may get a moonship, not space shuttle Discovery31.12.2025
- ‘More should be done’: UN pushes Syrian regime on justice for Druze, Alawites and minority groups
- Hot Electric Vehicles for 2023
- The 12 biggest space stories of 2025 — according to you
- Sound Propensities: 20 Methods for helping Your Insusceptible Framework
- Who plays Moana in the live-action remake? What to know about Catherine Lagaʻaia.
- Defense Minister Katz moves to extend IDF service to 36 months
- 2 of Earth's rarest lightning phenomena captured simultaneously in once-in-a-lifetime photo
- Figure out How to Store Your Gold Ventures: A Thorough Aide safely
- Figure out How to Reveal Stowed away Open Record Rewards
